Page last updated: 2024-11-03

ritanserin and Acute Edematous Pancreatitis

ritanserin has been researched along with Acute Edematous Pancreatitis in 1 studies

Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.

Research Excerpts

ExcerptRelevanceReference
"We investigated the effects of ketanserin, a S 2 (5-hydroxytryptamine 2; 5-HT 2)-serotonergic receptor antagonist, on cerulein-induced pancreatitis in the rat."7.68Effects of the S2-serotonergic receptor antagonist, ketanserin, on cerulein-induced pancreatitis in the rat. ( Furuta, S; Homma, T; Kawa, S; Kobayashi, M; Koiwai, T; Oguchi, H; Terashima, M, 1992)
"We investigated the effects of ketanserin, a S 2 (5-hydroxytryptamine 2; 5-HT 2)-serotonergic receptor antagonist, on cerulein-induced pancreatitis in the rat."3.68Effects of the S2-serotonergic receptor antagonist, ketanserin, on cerulein-induced pancreatitis in the rat. ( Furuta, S; Homma, T; Kawa, S; Kobayashi, M; Koiwai, T; Oguchi, H; Terashima, M, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oguchi, H1
Terashima, M1
Koiwai, T1
Kawa, S1
Furuta, S1
Kobayashi, M1
Homma, T1

Other Studies

1 other study available for ritanserin and Acute Edematous Pancreatitis

ArticleYear
Effects of the S2-serotonergic receptor antagonist, ketanserin, on cerulein-induced pancreatitis in the rat.
    Life sciences, 1992, Volume: 50, Issue:10

    Topics: Acute Disease; Amylases; Animals; Ceruletide; Dose-Response Relationship, Drug; Ketanserin; Male; Pa

1992